- Lobbying
- Lobbying by Sanofi-Aventis U.S. Inc
Lobbying Relationship
Bills mentioned
S.1679: Affordable Health Choices Act
Sponsor: Tom Harkin (D-Iowa)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Sheila Walcoff | 2006-07: Counselor to The Honorable Michael O. Leavitt (Immediate Office of the Secretary), U.S.Department of Health/Human Services; 2004-06: Assoc Commissioner for External Affairs, U.S. FDA; 1998-99: Majority Counsel, Armed Services Committee, U.S. House of Representatives Leavitt (Immediate Office of the Secretary), U.S. Dept of Health/Human Services; 2004-06: Assoc Commissioner for External Relations, U.S. FDA; 1998-99: Majority Counsel, Armed Services |
Paul Radensky MD | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Registration
Issue(s) they said they’d lobby about: FDA approval of follow on biologics, including S. 1679.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate